
    
      Patients receive Y-90 (yttrium) glass microspheres via percutaneous hepatic arterial
      infusion. Patients amy be retreated between 30-90 days after initial infusion. After
      completion of therapy, patients are followed for 30 days and then every 3 months for up to 2
      years.
    
  